Skip to content

Clinical trials

Phase 2 Cognitive Dysfunction trials in Spain

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Cognitive Dysfunction Phase: Phase 2 Country / region: Spain Clear all

13 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20051
20111
20172
20181
20191
20213
20221
20242
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed6
Active, not recruiting3
Terminated3
Recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AbbVie1
Acumen Pharmaceuticals1
Aelis Farma1
Araclon Biotech S.L.1
Avraham Pharmaceuticals Ltd1
Biogen1
Eisai Limited1
FUJIFILM Toyama Chemical Co., Ltd.1
Fundación FLS de Lucha Contra el Sida, las Enfermedades Infecciosas y la Promoción de la Salud y la Ciencia1
Inmune Bio, Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Cognitive Dysfunction13
Alzheimer Disease8
Dementia4
Memory Disorders3
Nervous System Diseases3
Neurodegenerative Diseases3
Brain Diseases2
Central Nervous System Diseases2
Mental Disorders2
Neurocognitive Disorders2

Trials

Showing 1 to 13 of 13. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.